// App-Quantinova.ai

887 : PAX5-PML Induces Pro B Acute Lymphoblastic Leukemia in Mice

Researchers

Presenter

  • Naoto Imoto

Principal Investigators

  • Shingo Kurahashi

  • Fumihiko Hayakawa

  • Takahiko Yasuda

  • Keiki Sugimoto

  • Yuki Kojima

  • Takanobu Morishita

  • Yuichiro Inagaki

  • Shinobu Tsuzuki

  • Tomoki Naoe

  • Hitoshi Kiyoi

Medical Centers

  • Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  • Department of Pathologic Oncology, Mie University Graduate School of Medicine, Mie, Japan

  • Department of Cellular Signaling, Tokyo University Graduate School of Medicine, Tokyo, Japan

  • Department of Hematology and Oncology, Nagoya university, Graduate school of Medicine, Nagoya-city, Japan

  • National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan

  • Department of Pediatrics, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan

Locations

  • Japan

Companies

  • Otsuka Pharmaceutica

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved